“Comparative Bioavailability of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) Vs. Minocycline Hydrochloride Extended Release 105-mg tablets After a Single Oral Dose: A Randomized, 3-way Crossover Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s289. doi:10.25251/skin.7.supp.289.